Officials at an Evansville hospital say about 560 patients received injections of a recalled pain medication that's been tied to an outbreak of a rare form of meningitis. A spokesman at St. Mary's Health says 10 of the roughly 250 of those patients the hospital has contacted so far are experiencing symptoms that could be consistent with fungal meningitis.
Officials say the hospital is taking the situation very seriously and is trying to contact the remaining patients. They add that the patients received the spinal injections of the steroid made by Framingham, Massachusetts based New England Compounding Center between July 1 and September 28 at Surgicare Cross Pointe, an outpatient surgery clinic in Evansville. Between 50 and 60 of the 560 patients had received multiple injections of the drug.
Officials say the hospital is taking the situation very seriously and is trying to contact the remaining patients. They add that the patients received the spinal injections of the steroid made by Framingham, Massachusetts based New England Compounding Center between July 1 and September 28 at Surgicare Cross Pointe, an outpatient surgery clinic in Evansville. Between 50 and 60 of the 560 patients had received multiple injections of the drug.
WebReadyTM Powered by WireReady® NSI
E-Mail
Print
